Health Care: Drugs

Emergent BioSolutions Inc (EBS: NYSE)

$30.29 -0.02 | -0.07%
04/28/17 - 09:41 AM ET
Company Profile
Price and Volume
Recent Price 30.31
52 Week High 41.91
52 Week Low 24.47
Avg. Daily Vol. (Mil) 0.32
Beta (3 year) 1.48
Share Related Items
Mkt Cap (Mil) 1,241.38
Shares Out (Mil) 40.96
Float (Mil) 30.80
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.00
Current Ratio 4.80
LT Debt/ Equity 0.42
Total Debt / Equity 0.45
Valuation Ratios
Price Earnings 26.80
Price/Sales 2.54
Price/Book 2.08
Price/Cash Flow 13.80
Per Share Data
Earnings 1.13
Sales 11.93
Book Value 14.56
Cash Flow 2.20
Business Summary
Emergent BioSolutions Inc is a specialty biopharmaceutical company It develops, manufactures, and delivers a portfolio of medical countermeasures for government agencies in the areas of biological and chemical threats and emerging infectious diseases.
General Information
400 Professional Drive
Suite 400
Gaithersburg, MD 20879
Industry : Drugs
Sector: Health Care
Employees: 1098
CEO: Daniel J. Abdun-Nabi
Short Interest
Current Month (Mil) 3.38
Previous Month (Mil) 3.26
Short Interest Ratio (Days) 10.20
Management Effectiveness
Return on Equity 8.70
Return on Assets 5.30
Return on Investments 6.10
Gross Margin 81.00
EBIT Margin 21.90
Profit Margin 10.60

Portfolios with EBS

Latest EBS Headlines from TheStreet

More Financial News for EBS

Press Releases for EBS

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter